<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-03-13</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000815838</issuerCik>
        <issuerName>NOVEN PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>NOVN</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001218321</rptOwnerCik>
            <rptOwnerName>OSS CAPITAL MANAGEMENT</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>598 MADISON AVENUE</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10022</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock ($.0001 par value)</value>
            </securityTitle>
            <transactionDate>
                <value>2008-03-13</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>100000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>10.92</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>3306690</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">This Form 4 is being filed to report that O.S.S. Capital Management LP, a Delaware limited partnership (the &quot;Investment
 Manager&quot;), Schafer Brothers LLC, a Delaware limited liability company (the &quot;SB LLC&quot;), Mr. Oscar S. Schafer (&quot;Mr. Schafer&quot;)
 and Mr. Andrew Goffe (&quot;Mr. Goffe&quot;, collectively with the Investment Manager, SB LLC and Mr. Shafer, the &quot;Reporting Persons&quot;)
 have purchased an additional 100,000 shares of Noven Pharmaceuticals Inc. (the &quot;Issuer&quot;) common shares.</footnote>
        <footnote id="F2">The Reporting Persons have investment discretion with respect to securities held by a Cayman Islands exempted company and two
 Delaware limited partnerships as more fully described in the Form 3 filed on July 16, 2007 (Accession Number:
 0000902664-07-002296), the Form 4 filed on August 8, 2007 (Accession Number: 0000902664-07-002474), the Form 4 filed on
 August 14, 2007 (Accession Number 0000902664-07-002630), the Form 4 filed on September 12, 2007 (Accession Number
 0000902664-07-002795), the Form 4 filed on September 14, 2007 (Accession Number 0000902664-07-002815) and the Form 4 filed
 on September 17, 2007 (Accession Number 0000902664-07-002830), the Form 4 filed on October 2, 2007 (Accession Number
 0000902664-07-002925).</footnote>
        <footnote id="F3">Each of the Reporting Persons may be deemed to beneficially own 3,306,690 shares of common stock, which represent, together,
 approximately 13.5% of the outstanding shares of common stock. Each of the Reporting Persons disclaims beneficial ownership
 of the securities included in this report and this report shall not be deemed an admission that any of the Reporting Persons
 is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.</footnote>
    </footnotes>

    <remarks>This report shall not be deemed an admission that the Reporting Persons are or have been the beneficial owners of such
 securities for purposes of Section 16 or for any other purpose.</remarks>

    <ownerSignature>
        <signatureName>By: /s/ Oscar S. Schafer</signatureName>
        <signatureDate>2008-03-17</signatureDate>
    </ownerSignature>
</ownershipDocument>
